PUBLISHER: TechNavio | PRODUCT CODE: 2125990
PUBLISHER: TechNavio | PRODUCT CODE: 2125990
Global Pharmacovigilance Market 2026-2030
The global pharmacovigilance market is forecasted to grow by USD 3377.4 mn during 2025-2030, accelerating at a CAGR of 6.1% during the forecast period. The report on the global pharmacovigilance market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of chronic diseases and rise of polypharmacy, increasing stringency of regulatory frameworks and international harmonization efforts, rapid technological integration and shift toward automated safety data management.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 5.7% |
| CAGR | 6.1% |
| Incremental Value | $3377.4 mn |
Technavio's global pharmacovigilance market is segmented as below:
By Service
- In-house
- Contract outsourcing
By Deployment
- Cloud-based
- On-premises
- Hybrid
By Type
- Spontaneous reporting
- Cohort event monitoring
- Intensified ADR reporting
- Targeted spontaneous reporting
- EHR mining
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of ai and machine learning in signal detection as one of the prime reasons driving the global pharmacovigilance market growth during the next few years. Also, shift toward active surveillance and real world evidence integration and rising adoption of outsourcing and functional service provider models will lead to sizable demand in the market.
The report on the global pharmacovigilance market covers the following areas:
- Global pharmacovigilance market sizing
- Global pharmacovigilance market forecast
- Global pharmacovigilance market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmacovigilance market vendors that include AB Cube SARL, Allucent, APCER Life Sciences Inc., ArisGlobal LLC, ClinChoice Inc., Ennov SAS, Eversana Life Science Services LLC, EXTEDO GmbH, Fortrea Holdings Inc, Freyr Software Services, ICON plc, IQVIA Holdings Inc., MakroCare, Medpace Holdings Inc., Navitas Life Sciences, Parexel International Corp., ProPharma Group Holdings LLC, Syneos Health Inc., Veristat LLC, Worldwide Clinical Trials Holdings. Also, the global pharmacovigilance market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Service
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Pharmacovigilance Market 2020 - 2024
- Historic Market Size - Data Table on Global Pharmacovigilance Market 2020 - 2024 ($ million)
- 5.2 Service segment analysis 2020 - 2024
- Historic Market Size - Service Segment 2020 - 2024 ($ million)
- 5.3 Deployment segment analysis 2020 - 2024
- Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Pharmacovigilance Market
- 6.2 Impact of Geopolitical Conflicts on Global Pharmacovigilance Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Service
- 8.1 Market segments
- 8.2 Comparison by Service
- 8.3 In-house - Market size and forecast 2025-2030
- 8.4 Contract outsourcing - Market size and forecast 2025-2030
- 8.5 Market opportunity by Service
- Market opportunity by Service ($ million)
9 Market Segmentation by Deployment
- 9.1 Market segments
- 9.2 Comparison by Deployment
- 9.3 Cloud-based - Market size and forecast 2025-2030
- 9.4 On-premises - Market size and forecast 2025-2030
- 9.5 Hybrid - Market size and forecast 2025-2030
- 9.6 Market opportunity by Deployment
- Market opportunity by Deployment ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Spontaneous reporting - Market size and forecast 2025-2030
- 10.4 Cohort event monitoring - Market size and forecast 2025-2030
- 10.5 Intensified ADR reporting - Market size and forecast 2025-2030
- 10.6 Targeted spontaneous reporting - Market size and forecast 2025-2030
- 10.7 EHR mining - Market size and forecast 2025-2030
- 10.8 Market opportunity by Type
- Market opportunity by Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 South Africa - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Israel - Market size and forecast 2025-2030
- 12.6.6 UAE - Market size and forecast 2025-2030
- 12.6.7 Argentina - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global burden of chronic diseases and rise of polypharmacy
- Increasing stringency of regulatory frameworks and international harmonization efforts
- Rapid technological integration and shift toward automated safety data management
- 13.2 Market challenges
- Complexities in big data integration and multimodal source management
- Global regulatory heterogeneity and stringent compliance standards
- Scarcity of specialized talent and technical proficiency gap
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and machine learning in signal detection
- Shift toward active surveillance and real world evidence integration
- Rising adoption of outsourcing and functional service provider models
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AB Cube SARL
- AB Cube SARL - Overview
- AB Cube SARL - Product / Service
- AB Cube SARL - Key offerings
- SWOT
- 15.5 ArisGlobal LLC
- ArisGlobal LLC - Overview
- ArisGlobal LLC - Product / Service
- ArisGlobal LLC - Key offerings
- SWOT
- 15.6 Ennov SAS
- Ennov SAS - Overview
- Ennov SAS - Product / Service
- Ennov SAS - Key offerings
- SWOT
- 15.7 Eversana Life Science Services LLC
- Eversana Life Science Services LLC - Overview
- Eversana Life Science Services LLC - Product / Service
- Eversana Life Science Services LLC - Key offerings
- SWOT
- 15.8 EXTEDO GmbH
- EXTEDO GmbH - Overview
- EXTEDO GmbH - Product / Service
- EXTEDO GmbH - Key offerings
- SWOT
- 15.9 Fortrea Holdings Inc
- Fortrea Holdings Inc - Overview
- Fortrea Holdings Inc - Product / Service
- Fortrea Holdings Inc - Key offerings
- SWOT
- 15.10 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 15.11 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 15.12 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
- 15.13 Navitas Life Sciences
- Navitas Life Sciences - Overview
- Navitas Life Sciences - Product / Service
- Navitas Life Sciences - Key offerings
- SWOT
- 15.14 Parexel International Corp.
- Parexel International Corp. - Overview
- Parexel International Corp. - Product / Service
- Parexel International Corp. - Key offerings
- SWOT
- 15.15 ProPharma Group Holdings LLC
- ProPharma Group Holdings LLC - Overview
- ProPharma Group Holdings LLC - Product / Service
- ProPharma Group Holdings LLC - Key news
- ProPharma Group Holdings LLC - Key offerings
- SWOT
- 15.16 Syneos Health Inc.
- Syneos Health Inc. - Overview
- Syneos Health Inc. - Product / Service
- Syneos Health Inc. - Key offerings
- SWOT
- 15.17 Veristat LLC
- Veristat LLC - Overview
- Veristat LLC - Product / Service
- Veristat LLC - Key offerings
- SWOT
- 15.18 Worldwide Clinical Trials Holdings
- Worldwide Clinical Trials Holdings - Overview
- Worldwide Clinical Trials Holdings - Product / Service
- Worldwide Clinical Trials Holdings - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
